LIMS aids cancer research
15 March 2007Tweet
Cell Genesys, a Californian cancer research organisation, has selected the Thermo Scientific Darwin v2.0 LIMS product.
Darwin was designed specifically for pharmaceutical R&D and QA/QC applications. Charlene Banard, vice president of the quality control department at Cell Genesys explained that Darwin’s user interface, low cost of ownership and ease of implementation were key factors in the decision.
Thermo Fisher Scientific’s quality system and coding practices also played a key part. In particular, its use of open standards means Cell Genesys can easily keep up to date with industry changes.
‘The implementation of Darwin LIMS is one of the key activities we are undertaking to better enable our organization to develop and commercialize novel biological therapies for patients with cancer,’ Banard said.